[Asia Economy Reporter Kwon Jaehee] MetabioMed announced on the 27th that it will invest 10 billion KRW in building a new factory to increase production capacity. This amount corresponds to 16.42% of its equity capital.
The investment period is from June 1, 2022, to December 30, 2022.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
